AG0035G0

50-56-6 | L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1→6)-disulfide

Chemical structure of L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1→6)-disulfide, CAS 50-56-6
AG0035G0
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 50-56-6
Catalog Number AG0035G0(AGN-PC-0S8L6F)
Chemical Name L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1→6)-disulfide
EC Number 200-048-4
IUPAC Name (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
InChI Key XNOPRXBHLZRZKH-DSZYJQQASA-N
MDL Number MFCD00076731
Molecular Formula C43H66N12O12S2
Molecular Weight 1007.1873
SMILES C(=O)(N1[C@H](C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CCC1)[C@H]1NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)C([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H](CSSC1)N)Cc1ccc(cc1)O
UNII 1JQS135EYN
Synonyms
Ocytocin, Oxytocin, Pitocin, Syntocinon, OXYTOCIN, Pitocin, 50-56-6, Ocytocin, Endopituitrina, Orasthin, Syntocinon, Oxitocina, Oxytocine, Oxytocinum, Oxytocic hormone, (1-Hemicystine)oxytocin, Piton S, 3-Isoleucine-8-leucine vasopressin, UNII-1JQS135EYN, Oxystin, Partocon, alpha-Hypophamine, Synthetic oxytocin, 1JQS135EYN, Ocytocinum, Syntocinone, Oxtocin, Presoxin, Synpitan, Syntocin, Utedrin, Uteracon, Di-sipidin, CHEBI:7872, CHEMBL395429, Nobitocin S, Atonin O, Oxetakain [Czech], Ossitocina [DCIT], MFCD00076731, Oxytocine [INN-French], Oxytocinum [INN-Latin], Oxitocina [INN-Spanish], Posterior pituitary extract, OXT, HSDB 2182, Ossitocina, Oxetakain, Oxoject, EINECS 200-048-4, Oxytocin (Syntocinon), BRN 3586108, [3H]oxytocin, 1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide, L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide, Vasopressin, 3-L-isoleucine-8-L-leucine-, OXYTOCIN 5 USP UNITS IN DEXTROSE 5%, OXYTOCIN 10 USP UNITS IN DEXTROSE 5%, OXYTOCIN 20 USP UNITS IN DEXTROSE 5%, [3H]OT (human, mouse, rat), Oxytocin [USP:INN:BAN:JAN], Syntocinon (TN), Oxytocin (TN), Oxytocin,(S), (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide, L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-6)-disulfide, C43H66N12O12S2, Pitocin (TN), SCHEMBL29048, Oxytocin (JP17/USP/INN), GTPL2174, GTPL2176, DTXSID8048361, BCBcMAP01_000094, XNOPRXBHLZRZKH-DSZYJQQASA-N, A-HYPOPHAMINEOXYTOCICHORMONE, AC1L9735, BDBM50205990, TI-001, AKOS015994657, HS-2021, NCGC00167132-01, AC-28730, AB0007936, FT-0658171, 6369-EP2272841A1, 6369-EP2292621A1, 6369-EP2301936A1, 6369-EP2308479A2, 6369-EP2311811A1, C00746, D00089, 076O731, SR-01000945111, SR-01000945111-1, W-105951, Oxytocin, European Pharmacopoeia (EP) Reference Standard, Oxytocin, United States Pharmacopeia (USP) Reference Standard, Oxytocin, lyophilized powder, ~15 IU/mg solid (Prepared from synthetic oxytocin), (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide, (S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydrox, L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-->6)-disulfide, Otx, ybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide, Oxytocin acetate, perlacton, |A-Hypophamine, Oxytocin-, D0M3FJ, D0T6FH, Oxytocin [USAN:BAN:INN:JAN], Oxytocin [USAN:INN:BAN:JAN], CID439302, C43-H66-N12-O12-S2, Oxytocin (intranasal/ muco system, autism), B4723, D010121, OT, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, cyclic 1-6 disulfide, 34330-23-9,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited